We are live on ! Find out more
SM

Sabby Management Portfolio holdings

AUM $45.1M
1-Year Est. Return 74.25%
This Fund
S&P 500
This Quarter Est. Return
+0.11%
1 Year Est. Return
-74.25%
3 Year Est. Return
-95.86%
5 Year Est. Return
-99.36%
10 Year Est. Return
-99.46%
AUM
$709M
AUM Growth
+$195M
Cap. Flow
-$68.5M
Cap. Flow %
-9.65%
Top 10 Hldgs %
69.09%
Holding
206
New
48
Increased
50
Reduced
50
Closed
43

Top Buys

Rank Stock Value
1
ATER icon
Aterian
ATER
+$8.44M
2
COCP icon
Cocrystal Pharma
COCP
+$7.74M
3
RCON icon
Recon Technology
RCON
+$7.52M
4
LNAI
Lunai Bioworks
LNAI
+$5.46M
5
KRBP
Kiromic BioPharma, Inc. Common Stock
KRBP
+$4.18M

Top Sells

Rank Stock Value
1
VANI icon
Vivani Medical
VANI
+$4.81M
2
PENN icon
PENN Entertainment
PENN
+$4.24M
3
VTSI icon
VirTra
VTSI
+$3.45M
4
ASXC
Asensus Surgical, Inc.
ASXC
+$3.42M
5
RVPH
REVIVA PHARMA HLDGS INC
RVPH
+$2.4M

Sector Composition

Rank Sector Weight
1 Healthcare 10.24%
2 Consumer Discretionary 1.47%
3 Technology 1.37%
4 Financials 1.09%
5 Consumer Staples 0.9%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SPI
1
PUT
DELISTED
SPI Energy Co., Ltd. Ordinary Shares
SPI
$40.5M 5.71%
3,714
-1,854
-33% -$11.9K
OEF icon
2
PUT
iShares S&P 100 ETF
OEF
$19.8B
$29.7M 4.18%
1,294
-810
-38% -$154K
SRNE
3
PUT
DELISTED
Sorrento Therapeutics, Inc.
SRNE
$19.6M 2.77%
20,242
+1,936
+11% +$15.4K
SPY icon
4
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$783B
$18.6M 2.62%
434
-400
-48% -$167K
XNTK icon
5
PUT
State Street SPDR NYSE Technology ETF
XNTK
$2B
$17.4M 2.45%
1,284
-1,165
-48% -$174K
ATOS icon
6
PUT
Atossa Therapeutics
ATOS
$24.1M
$16.1M 2.27%
1,696
+851
+101% +$45.1K
SRNE
7
DELISTED
Sorrento Therapeutics, Inc.
SRNE
$11.6M 1.64%
1,197,976
+133,043
+12% +$1.06M
ZVRA icon
8
PUT
Zevra Therapeutics
ZVRA
$575M
$9.12M 1.29%
7,117
+2,094
+42% +$22.5K
COCP icon
9
Cocrystal Pharma
COCP
$12.9M
$7.64M 1.08%
+509,221
New +$7.74M
LNAI
10
Lunai Bioworks
LNAI
$10.2M
$6.67M 0.94%
+16,771
New +$5.46M
ATOS icon
11
Atossa Therapeutics
ATOS
$24.1M
$6.61M 0.93%
69,732
+53,583
+332% +$2.84M
ORIO
12
PUT
Orion Digital Corp
ORIO
$15.6M
$6.42M 0.91%
2,728
+627
+30% +$15K
ATER icon
13
Aterian
ATER
$4.21M
$6.33M 0.89%
+36,083
New +$8.44M
VXX icon
14
iPath Series B S&P 500 VIX Short-Term Futures ETN
VXX
$159M
$5.62M 0.79%
11,913
+3,710
+45% +$2.21M
KNDI
15
PUT
Kandi Technologies Group
KNDI
$63.5M
$5.54M 0.78%
9,267
-1,470
-14% -$8.41K
CBAT icon
16
PUT
CBAK Energy Technology Ltd
CBAT
$43.6M
$5.22M 0.74%
11,089
-543
-5% -$2.42K
RCON icon
17
Recon Technology
RCON
$39.6M
$4.03M 0.57%
+51,667
New +$7.52M
HMCO
18
DELISTED
HumanCo Acquisition Corp. Class A Common Stock
HMCO
$3.94M 0.56%
404,185
+67,974
+20% +$673K
NBEV
19
DELISTED
NewAge, Inc. Common Stock (Delaware)
NBEV
$3.86M 0.54%
1,729,931
-634,763
-27% -$1.48M
RIOT icon
20
PUT
Riot Platforms
RIOT
$8.03B
$3.84M 0.54%
1,019
+119
+13% +$4.25K
ORIO
21
Orion Digital Corp
ORIO
$15.6M
$3.61M 0.51%
153,423
+64,814
+73% +$1.55M
VINC
22
DELISTED
Vincerx Pharma, Inc. Common Stock
VINC
$3.52M 0.5%
13,553
+9,406
+227% +$2.87M
BFLY icon
23
CALL
Butterfly Network
BFLY
$1.88B
$3.49M 0.49%
2,410
+2,013
+507% +$27.2K
WIMI
24
WiMi Hologram Cloud
WIMI
$21M
$3.44M 0.48%
62,610
-35,469
-36% -$1.99M
IONS icon
25
PUT
Ionis Pharmaceuticals
IONS
$9.14B
$3.35M 0.47%
841
+11
+1% +$431
1
2 3 4 5

Similar funds

CG
Circumference Group Little Rock, Arkansas $44.6M AUM 5.21% 1-Year Est. Return
OC
Optimas Capital Central, Hong Kong $44.5M AUM 24.43% 1-Year Est. Return
ICCON
Investment Counsel Company of Nevada Las Vegas, Nevada $44.5M AUM 21.97% 1-Year Est. Return
PCM
Prentice Capital Management Greenwich, Connecticut $45.7M AUM 2.65% 1-Year Est. Return
CAS
CTC Alternative Strategies Chicago, Illinois $44M AUM 43.15% 1-Year Est. Return
CM
Crestline Management Fort Worth, Texas $46.3M AUM 48.82% 1-Year Est. Return
MCMC
Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return
CTC
Corundum Trust Company Sioux Falls, South Dakota $43.8M AUM 20.07% 1-Year Est. Return

Sabby Management's Q2 2021 Portfolio in Review

As of Q2 2021, Sabby Management held 206 positions worth $709M, up 38% from $514M the previous quarter. Its ten largest holdings account for 69% of the portfolio.

Sabby Management withdrew a net $68.5M in Q2 2021, closing 43 positions and reducing 50 holdings. Its most notable exit was PENN Entertainment, an estimated $4.24M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 10% of assets, down from 13% a quarter earlier, followed by Consumer Discretionary and Technology.

Against the trend, Sabby Management opened a new position in Aterian worth $6.33M.

  • Sabby Management's largest Q2 2021 buy was Aterian: 36,083 shares worth $6.33M.
  • Sabby Management added most to Vincerx Pharma, Inc. Common Stock in Q2 2021, an estimated $2.87M increase.
  • Sabby Management's biggest Q2 2021 reduction was Vivani Medical, cutting an estimated $4.81M.
  • Sabby Management fully exited PENN Entertainment in Q2 2021, selling an estimated $4.24M.
  • Sabby Management's ten largest holdings make up 69% of its $709M portfolio in Q2 2021.
  • Sabby Management opened 48 new positions and closed 43 in Q2 2021.
  • Sabby Management's portfolio value rose 38% quarter-over-quarter to $709M.

Based on Sabby Management's 13F filing for Q2 2021, filed 16 Aug 2021.